Bassam Damaj, President and CEO at APRICUS BIOSCIENCES, INC. (APRI), bought 249,762 shares at $2.77 ($2K) on 2012-08-21, disclosed to the SEC on 2012-08-23.
Open-market purchase of $2k APRI by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.77 | 760 | $2K | 100.0% |
| 2 | $0.00 | 249,002 | $0 | 0.0% |
| Total | $0.01 avg | 249,762 | $2K | 100% |
| Filing → |
| APRI | BUY | 2012-08-21 | $4K | — | Filing → |